Mortality Associated With Systemic Lupus Erythematosus in France Assessed by Multiple-Cause-of-Death Analysis

被引:152
作者
Thomas, Guillemette [1 ,2 ]
Mancini, Julien [2 ,3 ]
Jourde-Chiche, Noemie [2 ,3 ]
Sarlon, Gabrielle [2 ,3 ]
Amoura, Zahir [4 ,5 ]
Harle, Jean-Robert [1 ,2 ]
Jougla, Eric [6 ]
Chiche, Laurent [1 ,2 ]
机构
[1] Hop Conception, AP HM, F-13005 Marseille, France
[2] Univ Aix Marseille, Marseille, France
[3] Hop La Timone, AP HM, Marseille, France
[4] French Reference Ctr System Lupus Erythematosus, AP HP, Paris, France
[5] Hop La Pitie Salpetriere, Paris, France
[6] INSERM, CepiDc, F-94275 Le Kremlin Bicetre, France
关键词
CARDIOVASCULAR-DISEASE; MULTICENTER COHORT; LIFE EXPECTANCY; KOREAN PATIENTS; POPULATION; ATHEROSCLEROSIS; MANIFESTATIONS; EPIDEMIOLOGY; PREVENTION; SURVIVAL;
D O I
10.1002/art.38731
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To assess the mortality profile of systemic lupus erythematosus (SLE) patients in France using multiple-cause-of-death analysis. Methods. Data were collected between 2000 and 2009 in the French Epidemiological Center for the Medical Causes of Death database, and death certificates issued upon the death of an adult for whom SLE was an underlying cause of death (UCD) or a non-underlying cause of death (NUCD) were evaluated using multiple-cause-of-death analysis. Sex, age, sex ratio, standardized mortality rates, as well as frequency of the various causes of death were assessed, at both a national and a regional level. For the main causes of death, the observed number of deaths in relation to the expected number of deaths (O:E ratio) (standardized for age and sex) was calculated. Results. During the study period, 1,593 deaths related to SLE were identified. The mean +/- SD age at death was 63.5 +/- 18.4 years and the sex ratio (female: male) was 3.5. The mean standardized mortality rate was 3.2 per 1 million people (range 2.7-4.1). When SLE was the UCD (n = 637), the main NUCDs were cardiovascular diseases (49.5%), infectious diseases (24.5%), and renal failure (23.2%). When SLE was an NUCD (n = 956), the most common UCDs were cardiovascular diseases (35.7%), neoplasms (13.9%), and infectious diseases (10.3%). The overall O: E ratio was > 1 for infectious and cardiovascular diseases and renal failure (especially among people < 40 years of age for the latter 2 causes), but was < 1 for neoplasms. Conclusion. Cardiovascular disease is the leading cause of death associated with SLE in France.
引用
收藏
页码:2503 / 2511
页数:9
相关论文
共 35 条
  • [1] Deaths associated with acquired haemophilia in France from 2000 to 2009: multiple cause analysis for best care strategies
    Aouba, A.
    Rey, G.
    Pavillon, G.
    Jougla, E.
    Rothschild, C.
    Torchet, M-F
    Guillevin, L.
    Hermine, O.
    Aouba, A.
    [J]. HAEMOPHILIA, 2012, 18 (03) : 339 - 344
  • [2] Premature coronary-artery atherosclerosis in systemic lupus erythematosus
    Asanuma, Y
    Oeser, A
    Shintani, AK
    Turner, E
    Olsen, N
    Fazio, S
    Linton, MF
    Raggi, P
    Stein, CM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (25) : 2407 - 2415
  • [3] Mortality in systemic lupus erythematosus
    Bernatsky, S.
    Boivin, J. -F.
    Joseph, L.
    Manzi, S.
    Ginzler, E.
    Gladman, D. D.
    Urowitz, M.
    Fortin, P. R.
    Petri, M.
    Barr, S.
    Gordon, C.
    Bae, S. -C.
    Isenberg, D.
    Zoma, A.
    Aranow, C.
    Dooley, M. -A.
    Nived, O.
    Sturfelt, G.
    Steinsson, K.
    Alarcon, G.
    Senecal, J. -L.
    Zummer, M.
    Hanly, J.
    Ensworth, S.
    Pope, J.
    Edworthy, S.
    Rahman, A.
    Sibley, J.
    El-Gabalawy, H.
    McCarthy, T.
    Pierre, Y. St.
    Clarke, A.
    Ramsey-Goldman, R.
    [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (08): : 2550 - 2557
  • [4] Bernatsky Sasha, 2005, Curr Rheumatol Rep, V7, P476
  • [5] Cancer risk in systemic lupus: An updated international multi-centre cohort study
    Bernatsky, Sasha
    Ramsey-Goldman, Rosalind
    Labrecque, Jeremy
    Joseph, Lawrence
    Boivin, Jean-Francois
    Petri, Michelle
    Zoma, Asad
    Manzi, Susan
    Urowitz, Murray B.
    Gladman, Dafna
    Fortin, Paul R.
    Ginzler, Ellen
    Yelin, Edward
    Bae, Sang-Cheol
    Wallace, Daniel J.
    Edworthy, Steven
    Jacobsen, Soren
    Gordon, Caroline
    Dooley, Mary Anne
    Peschken, Christine A.
    Hanly, John G.
    Alarcon, Graciela S.
    Nived, Ola
    Ruiz-Irastorza, Guillermo
    Isenberg, David
    Rahman, Anisur
    Witte, Torsten
    Aranow, Cynthia
    Kamen, Diane L.
    Steinsson, Kristjan
    Askanase, Anca
    Barr, Susan
    Criswell, Lindsey A.
    Sturfelt, Gunnar
    Patel, Neha M.
    Senecal, Jean-Luc
    Zummer, Michel
    Pope, Janet E.
    Ensworth, Stephanie
    El-Gabalawy, Hani
    McCarthy, Timothy
    Dreyer, Lene
    Sibley, John
    St Pierre, Ivan
    Clarke, Ann E.
    [J]. JOURNAL OF AUTOIMMUNITY, 2013, 42 : 130 - 135
  • [6] Björnådal L, 2004, J RHEUMATOL, V31, P713
  • [7] Boyle P, 1991, IARC Sci Publ, P126
  • [8] Lack of recording of systemic lupus erythematosus in the death certificates of lupus patients
    Calvo-Alén, J
    Alarcón, GS
    Campbell, R
    Fernández, M
    Reveille, JD
    Cooper, GS
    [J]. RHEUMATOLOGY, 2005, 44 (09) : 1186 - 1189
  • [9] Morbidity and mortality in systemic lupus erythematosus during a 10-year period -: A comparison of early and late manifestations in a cohort of 1,000 patients
    Cervera, R
    Khamashta, MA
    Font, J
    Sebastiani, GD
    Gil, A
    Lavilla, P
    Mejía, JC
    Aydintug, AC
    Chwalinska-Sadowska, H
    de Ramón, E
    Fernández-Nebro, A
    Galeazzi, M
    Valen, M
    Mathieu, A
    Houssiau, FD
    Caro, N
    Alba, P
    Ramos-Casals, M
    Ingelmo, M
    Hughes, GRV
    [J]. MEDICINE, 2003, 82 (05) : 299 - 308
  • [10] Mortality and cancer incidence in Korean patients with systemic lupus erythematosus: results from the Hanyang Lupus Cohort in Seoul, Korea
    Chun, BC
    Bae, SC
    [J]. LUPUS, 2005, 14 (08) : 635 - 638